|
|
|
|
LEADER |
01000caa a22002652c 4500 |
001 |
NLM318715538 |
003 |
DE-627 |
005 |
20250228130951.0 |
007 |
cr uuu---uuuuu |
008 |
231225s2021 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1002/adma.202007247
|2 doi
|
028 |
5 |
2 |
|a pubmed25n1062.xml
|
035 |
|
|
|a (DE-627)NLM318715538
|
035 |
|
|
|a (NLM)33306220
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Zeng, Ziling
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Activatable Polymer Nanoenzymes for Photodynamic Immunometabolic Cancer Therapy
|
264 |
|
1 |
|c 2021
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 24.07.2024
|
500 |
|
|
|a Date Revised 24.07.2024
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a © 2020 Wiley-VCH GmbH.
|
520 |
|
|
|a Tumor immunometabolism contributes substantially to tumor proliferation and immune cell activity, and thus plays a crucial role in the efficacy of cancer immunotherapy. Modulation of immunometabolism to boost cancer immunotherapy is mostly based on small-molecule inhibitors, which often encounter the issues of off-target adverse effects, drug resistance, and unsustainable response. In contrast, enzymatic therapeutics can potentially bypass these limitations but has been less exploited. Herein, an organic polymer nanoenzyme (SPNK) with near-infrared (NIR) photoactivatable immunotherapeutic effects is reported for photodynamic immunometabolic therapy. SPNK is composed of a semiconducting polymer core conjugated with kynureninase (KYNase) via PEGylated singlet oxygen (1 O2 ) cleavable linker. Upon NIR photoirradiation, SPNK generates 1 O2 not only to exert photodynamic effect to induce the immunogenic cell death of cancer, but also to unleash KYNase and trigger its activity to degrade the immunosuppressive kynurenine (Kyn). Such a combinational effect mediated by SPNK promotes the proliferation and infiltration of effector T cells, enhances systemic antitumor T cell immunity, and ultimately permits inhibition of both primary and distant tumors in living mice. Therefore, this study provides a promising photodynamic approach toward remotely controlled enzymatic immunomodulation for improved anticancer therapy
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a cancer therapy
|
650 |
|
4 |
|a immunotherapy
|
650 |
|
4 |
|a organic nanoparticles
|
650 |
|
4 |
|a photoactivation
|
650 |
|
4 |
|a photodynamic therapy
|
650 |
|
7 |
|a Polymers
|2 NLM
|
650 |
|
7 |
|a Singlet Oxygen
|2 NLM
|
650 |
|
7 |
|a 17778-80-2
|2 NLM
|
650 |
|
7 |
|a Photosensitizing Agents
|2 NLM
|
700 |
1 |
|
|a Zhang, Chi
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Li, Jingchao
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Cui, Dong
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Jiang, Yuyan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Pu, Kanyi
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 33(2021), 4 vom: 01. Jan., Seite e2007247
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnas
|
773 |
1 |
8 |
|g volume:33
|g year:2021
|g number:4
|g day:01
|g month:01
|g pages:e2007247
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202007247
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 33
|j 2021
|e 4
|b 01
|c 01
|h e2007247
|